Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare type of blood cancer that starts in your plasma cells.

Idecabtagene vicleucel induced high complete response and minimal residual disease negativity rates in multiple myeloma after ...

A five-year study has found that adding daratumumab (D) to the current standard-of-care triplet therapy bortezomib, lenalidomide, and dexamethasone (VRd) produced deeper and more durable minimal ...

Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for ...

Films like Strong: Living with Multiple Myeloma are essential. Multiple Myeloma is not exactly high on the list of diseases ...

The main focus right now in the myeloma paradigm of treatment is, okay, how do we harness the best power of CAR-T? We're doing it later in the treatment of myeloma. We've tried to move it earlier, and ...

Genetic testing should be used to help doctors spot high-risk cases of myeloma and enable targeted treatments, say ...

Multiple Genetic Abnormalities Lead to Poor Prognosis Around 5900 people are diagnosed with myeloma each year ... chemotherapy, and stem cell transplants. More than half of patients survive ...

Ciltacabtagene autoleucel improved minimal residual disease negativity and sustained responses vs standard care in ...

Offering state-of-the-art genetic testing to patients with the blood cancer myeloma would help doctors spot those with the most aggressive forms of the disease so that their cancer can be targeted ...

Anna-Louise Bates' husband Zachary Stubbings has died after living with blood cancer from years of exposure to toxic ...